← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2019Last known activity
Mar 31, 2023
Timeline
2010s
- Jun 1, 2019
Evergreen Therapeutics— Founded
Drugs by trial phase (8 distinct, 6 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT05170048Lead sponsorPhase 2Mar 31, 2023
- NCT05077215Lead sponsorPhase 3Jan 31, 2022
- NCT05106127Lead sponsorPhase 2Dec 31, 2021
- NCT04561180Lead sponsorPhase 2Dec 31, 2020
- NCT03527472CollaboratorPhase 2Aug 23, 2018
- NCT07281105Lead sponsorPhase 2Aug 23, 2018
Details
- Founded
- Bethesda, MD, US Jun 1, 2019
- Last known activity
- Mar 31, 2023